Cover Image
Market Research Report

Breast Biopsy Market by Product (Needles, Tables, Assay Kit), Type (Needle Biopsy (CNB, FNAB, VAB), Liquid Biopsy (CTC, ctDNA)), Guidance (Image-Guided (Mammography, Ultrasound, MRI), Liquid Biopsy)-Global Forecasts to 2025

Published by MarketsandMarkets Product code 962612
Published Content info 183 Pages
Delivery time: 1-2 business days
Price
Back to Top
Breast Biopsy Market by Product (Needles, Tables, Assay Kit), Type (Needle Biopsy (CNB, FNAB, VAB), Liquid Biopsy (CTC, ctDNA)), Guidance (Image-Guided (Mammography, Ultrasound, MRI), Liquid Biopsy)-Global Forecasts to 2025
Published: September 28, 2020 Content info: 183 Pages
Description

Title:
Breast Biopsy Market
by Product (Needles, Tables, Assay Kit), by Type (Needle Biopsy (CNB, FNAB, VAB), Liquid Biopsy (CTC, ctDNA)), Guidance (Image-Guided (Mammography, Ultrasound, MRI), Liquid Biopsy (NGS, PCR, Microarray-based)) - Global Forecasts to 2025.

The global breast biopsy market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period. The factors driving the growth of the market are growing incidence of breast cancer, increasing demand for minimally invasive and non-invasive procedures, and increasing number of breast cancer screening programs. However, stringent regulatory approval procedures, and product recalls are expected to restrain the growth of this market in the coming years.

Breast cancer is among the most common diseases affecting women in developed as well as developing countries. According to the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths in women across the globe. The increasing number of breast cancer cases has forced governments across the globe to raise awareness regarding the importance of early detection of breast cancer. Thus, surge in breast cancer incidence and favorable government guidelines are expected to support market growth.

The breast biopsy market is witnessing loss of business and the trend is expected to continue till December 2020. Unfavorable changes in regulations and guidelines are hampering the growth of this industry. Major regulatory authorities across the globe (such as CDC, WHO, MHRA, TGA, and EMA) have identified that breast cancer patients are at greater risk of COVID-19 infection than healthy adults. Thus, screening, diagnostic exams, and surgical procedures are being severely restricted or postponed at hospitals and breast centers. This is expected to cause disruption in the breast cancer diagnosis as well as treatment market.

"Assay Kits: The fastest-growing segment of breast biopsy market over the forecast period"

Based on product, the breast biopsy market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products. In the past two decades, personalized medicine has increasingly been recognized for its ability to detect cancer (including breast cancer) early and accurately. Promising role of liquid biopsy in the field of personalized medicine is expected to boost the segment growth.

"Core needle biopsy: The largest sub-segment of needle breast biopsy segment"

Based on type, the breast biopsy market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. In 2019, the needle breast biopsy held a major share of the breast biopsy market. Rising adoption of core needle biopsy by healthcare professionals due to advantages such as high sensitivity and specificity, and technological advancements are driving growth of the segment.

"Early cancer screening: The dominating application segment of breast biopsy market"

Based on application, the breast biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The early cancer screening segment accounted for largest share of the breast biopsy market in 2019. The major share of the segment is attributed to the rising incidence of breast cancer, growing awareness about early cancer screening, and development of breast cancer screening programs.

"North America: The largest share contributing reginal segment of the global breast biopsy market in 2019"

The breast biopsy market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. North America accounted for a major share of the breast biopsy market in 2019. The large share of the region can be attributed to the early adoption of newer breast biopsy technologies, ongoing technological advancements, rising breast cancer incidence, and the rapidly increasing aging population that is more prone to developing breast cancer.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-45%, Tier 2-34%, and Tier 3- 21%
  • By Designation: C-level-47%, Director-level-33%, and Others-20%
  • By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America-6%, and the Middle East & Africa-2%

The major players in the market include: Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), Illumina, Inc. (US), and Fluxion Biosciences Inc (US), among others.

Research Coverage:

This report studies the breast biopsy market based on product, type, guidance, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report:

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the breast biopsy market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the breast biopsy market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the breast biopsy market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
Product Code: MD 3615

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 GLOBAL BREAST BIOPSY MARKET: RESEARCH METHODOLOGY STEPS
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.1.2.2 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 END USER-BASED MARKET SIZE ESTIMATION
    • FIGURE 6 BREAST BIOPSY MARKET: END USER BASED ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 8 BREAST BIOPSY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 BREAST BIOPSY MARKET SHARE, BY TYPE, 2020 VS. 2025
    • FIGURE 10 BREAST BIOPSY MARKET, BY GUIDANCE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 BREAST BIOPSY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF BREAST BIOPSY MARKET

4 PREMIUM INSIGHTS

  • 4.1 BREAST BIOPSY: MARKET OVERVIEW
    • FIGURE 13 INCREASING PREVALENCE OF BREAST CANCER DRIVING GROWTH OF BREAST BIOPSY MARKET ACROSS THE GLOBE
  • 4.2 GEOGRAPHIC ANALYSIS: BREAST BIOPSY MARKET, BY PRODUCT AND REGION
    • FIGURE 14 ASSAY KITS SEGMENT WILL WITNESS HIGH GROWTH IN THE NORTH AMERICA MARKET IN 2025
  • 4.3 GEOGRAPHIC ANALYSIS: NEEDLE BREAST BIOPSY MARKET, BY TYPE AND REGION
    • FIGURE 15 CORE NEEDLE BIOPSY SEGMENT DOMINATED THE ASIA PACIFIC NEEDLE BREAST BIOPSY MARKET IN 2020
  • 4.4 LIQUID BREAST BIOPSY MARKET, BY GUIDANCE
    • FIGURE 16 NGS-BASED BIOPSY TO REGISTER SIGNIFICANT GROWTH IN THE GLOBAL LIQUID BIOPSY MARKET, BY GUIDANCE
  • 4.5 GEOGRAPHIC ANALYSIS: BREAST BIOPSY MARKET, BY APPLICATION AND REGION
    • FIGURE 17 EARLY CANCER SCREENING IS KEY APPLICATION IN EUROPEAN BREAST BIOPSY MARKET; THERAPY SELECTION TO REGISTER SUBSTANTIAL GROWTH
  • 4.6 GEOGRAPHIC SNAPSHOT OF THE BREAST BIOPSY MARKET
    • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 BREAST BIOPSY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing incidence of breast cancer
    • FIGURE 20 NUMBER OF BREAST CANCER CASES IN 2018, BY KEY COUNTRIES
      • 5.2.1.2 Increasing number of breast cancer screening programs
      • 5.2.1.3 Increasing demand for minimally invasive and non-invasive procedures
      • 5.2.1.4 Growing awareness regarding early detection of breast cancer
      • 5.2.1.5 Improved reimbursement scenario
    • TABLE 1 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risk of infections associated with the use of biopsy needles
      • 5.2.2.2 Stringent regulatory approval procedures
      • 5.2.2.3 Product recalls
    • TABLE 2 FDA INITIATED PRODUCT RECALLS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging economies offer high growth potential
      • 5.2.3.2 Emergence of liquid biopsy and promising clinical trials
    • TABLE 3 LIQUID BIOPSY CLINICL TRIALS
      • 5.2.3.3 Increasing public-private investments and funding
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Underdeveloped healthcare infrastructure and dearth of resources in developing countries
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM: BREAST BIOPSY MARKET
  • 5.5 TECHNOLOGY ANALYSIS
  • 5.6 IMPACT OF COVID-19 ON BREAST BIOPSY MARKET

6 BREAST BIOPSY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 4 BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • TABLE 5 BREAST BIOPSY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 6.2 BIOPSY NEEDLES
    • 6.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE REVENUE GROWTH
    • TABLE 6 BIOPSY NEEDLES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 7 BIOPSY NEEDLES MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 8 BIOPSY NEEDLES MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • 6.2.4 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 9 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.3 GUIDANCE SYSTEMS
    • 6.3.1 PROCEDURAL ADVANTAGES OF GUIDED BIOPSIES TO FUEL RAPID MARKET EXPANSION
    • TABLE 10 GUIDANCE SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.2 GUIDANCE SYSTEMS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 11 GUIDANCE SYSTEMS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.3.3 GUIDANCE SYSTEMS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 12 GUIDANCE SYSTEMS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • 6.3.4 GUIDANCE SYSTEMS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 13 GUIDANCE SYSTEMS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.4 BIOPSY TABLES
    • 6.4.1 INCREASINGLY USED TO PERFORM STEREOTACTIC BIOPSY PROCEDURES
    • TABLE 14 BIOPSY TABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.4.2 BIOPSY TABLES MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 15 BIOPSY TABLES MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.4.3 BIOPSY TABLES MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 16 BIOPSY TABLES MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • 6.4.4 BIOPSY TABLES MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 17 BIOPSY TABLES MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.5 ASSAY KITS
    • 6.5.1 PRODUCT APPROVAL AND LAUNCHES DRIVING SEGMENT GROWTH
    • TABLE 18 ASSAY KITS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.5.2 ASSAY KITS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 19 ASSAY KITS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.5.3 ASSAY KITS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 20 ASSAY KITS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • 6.5.4 ASSAY KITS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 21 ASSAY KITS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.6 LIQUID BIOPSY INSTRUMENTS
    • 6.6.1 ONGOING RESEARCH AND CLINICAL TRIALS EXPECTED TO DELIVER NOVEL SOLUTIONS IN THE MARKET
    • TABLE 22 LIQUID BIOPSY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.6.2 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 23 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.6.3 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 24 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • 6.6.4 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 25 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.7 LOCALIZATION WIRES
    • 6.7.1 MOST COMMONLY USED TO LOCATE BREAST ABNORMALITIES AND LUMPS
    • TABLE 26 LOCALIZATION WIRES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.7.2 LOCALIZATION WIRES MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 27 LOCALIZATION WIRES MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.7.3 LOCALIZATION WIRES MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 28 LOCALIZATION WIRES MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • 6.7.4 LOCALIZATION WIRES MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 29 LOCALIZATION WIRES MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.8 OTHER PRODUCTS
    • 6.8.1 RISING PATIENT POPULATION AND INCREASING ADOPTION OF BIOPSY PROCEDURES TO SUPPORT SEGMENT GROWTH
    • TABLE 30 OTHER PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.8.2 OTHER PRODUCTS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 31 OTHER PRODUCTS MARKET SPLIT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.8.3 OTHER PRODUCTS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 32 OTHER PRODUCTS MARKET SPLIT, BY GUIDANCE, 2018-2025 (USD MILLION)
    • 6.8.4 OTHER PRODUCTS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 33 OTHER PRODUCTS MARKET SPLIT, BY APPLICATION, 2018-2025 (USD MILLION)

7 BREAST BIOPSY MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 34 BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 7.2 NEEDLE BREAST BIOPSY
    • TABLE 35 BREAST BIOPSY MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2018-2025 (USD MILLION)
    • 7.2.1 CORE NEEDLE BIOPSY
      • 7.2.1.1 Procedural advantages of guidance system-based biopsy to drive revenue growth
    • TABLE 36 BREAST BIOPSY MARKET FOR CORE NEEDLE BIOPSY, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.2 VACUUM-ASSISTED BIOPSY (VAB)
      • 7.2.2.1 Technological advantages supporting growth of segment
    • TABLE 37 BREAST BIOPSY MARKET FOR VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.3 FINE NEEDLE ASPIRATION BIOPSY (FNAB)
      • 7.2.3.1 Increasingly being replaced by core needle biopsy procedures
    • TABLE 38 BREAST BIOPSY MARKET FOR FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 OPEN SURGICAL BREAST BIOPSY
    • TABLE 39 BREAST BIOPSY MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2018-2025 (USD MILLION)
    • 7.3.1 EXCISIONAL
      • 7.3.1.1 Risk of post-operative complications hindering growth of segment
    • TABLE 40 BREAST BIOPSY MARKET FOR EXCISIONAL, BY REGION, 2018-2025 (USD MILLION)
    • 7.3.2 INCISIONAL
      • 7.3.2.1 Performed when size of tumor is quite large
    • TABLE 41 BREAST BIOPSY MARKET FOR INCISIONAL, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 LIQUID BREAST BIOPSY
    • TABLE 42 BREAST BIOPSY MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2018-2025 (USD MILLION)
    • 7.4.1 CIRCULATING TUMOR CELLS
      • 7.4.1.1 Difficult to identify limited presence in blood sample
    • TABLE 43 BREAST BIOPSY MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2018-2025 (USD MILLION)
    • 7.4.2 CIRCULATING TUMOR DNA (CTDNA)
      • 7.4.2.1 Promising blood-based biomarker to monitor disease status
    • TABLE 44 BREAST BIOPSY MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2018-2025 (USD MILLION)
    • 7.4.3 OTHER BIOMARKERS
      • 7.4.3.1 Cell-free mRNA, miRNA, and tumor-educated platelets (TEP) used for early detection
    • TABLE 45 BREAST BIOPSY MARKET FOR OTHER BIOMARKERS, BY REGION, 2018-2025 (USD MILLION)

8 BREAST BIOPSY MARKET, BY GUIDANCE

  • 8.1 INTRODUCTION
    • TABLE 46 BREAST BIOPSY MARKET, BY GUIDANCE, 2018-2025 (USD MILLION)
  • 8.2 IMAGE GUIDED BIOPSY
    • TABLE 47 BREAST BIOPSY MARKET FOR IMAGE GUIDED BIOPSY, BY TYPE, 2018-2025 (USD MILLION)
    • 8.2.1 MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
      • 8.2.1.1 Increasing government-initiated breast screening programs to drive segment growth
    • TABLE 48 BREAST BIOPSY MARKET FOR MAMMOGRPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2018-2025 (USD MILLION)
    • 8.2.2 ULTRASOUND-GUIDED BIOPSY
      • 8.2.2.1 Advantages of technique resulting in rising adoption
    • TABLE 49 BREAST BIOPSY MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2025 (USD MILLION)
    • 8.2.3 MRI GUIDED BIOPSY
      • 8.2.3.1 High cost and low specificity affecting segment growth
    • TABLE 50 BREAST BIOPSY MARKET FOR MRI GUIDED BIOPSY, BY REGION, 2018-2025 (USD MILLION)
    • 8.2.4 OTHER GUIDANCE TECHNIQUES
      • 8.2.4.1 Ongoing research and clinical trials creating more opportunities in the market
    • TABLE 51 BREAST BIOPSY MARKET FOR OTHER GUIDANCE TECHNIQUES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 LIQUID BIOPSY
    • TABLE 52 BREAST BIOPSY MARKET FOR LIQUID BIOPSY, BY TYPE, 2018-2025 (USD MILLION)
    • 8.3.1 PCR-BASED BIOPSY
      • 8.3.1.1 Expected to hold major share of market over forecast period
    • TABLE 53 BREAST BIOPSY MARKET FOR PCR-BASED BIOPSY, BY REGION, 2018-2025 (USD MILLION)
    • 8.3.2 NGS-BASED BIOPSY
      • 8.3.2.1 Technological advancements and advantages expected to drive growth
    • TABLE 54 NGS-BASED TECHNOLOGIES FOR ONCOLOGY APPLICATIONS
    • TABLE 55 BREAST BIOPSY MARKET FOR NGS-BASED BIOPSY, BY REGION, 2018-2025 (USD MILLION)
    • 8.3.3 MICROARRAY-BASED BIOPSY
      • 8.3.3.1 Ongoing research and promising results expected to drive segment growth
    • TABLE 56 BREAST BIOPSY MARKET FOR MICROARRAY-BASED BIOPSY, BY REGION, 2018-2025 (USD MILLION)

9 BREAST BIOPSY MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 57 BREAST BIOPSY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 9.2 EARLY CANCER SCREENING
    • 9.2.1 GROWING AWARENESS ABOUT EARLY CANCER DETECTION DRIVING SEGMENT GROWTH
    • TABLE 58 BREAST BIOPSY MARKET FOR EARLY CANCER SCREENING, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 THERAPY SELECTION
    • 9.3.1 EMERGENCE OF PLASMA-BASED GENOTYPING EXPECTED TO DRIVE GROWTH IN DEVELOPED COUNTRIES
    • TABLE 59 BREAST BIOPSY MARKET FOR THERAPY SELECTION, BY REGION, 2018-2025 (USD MILLION)
  • 9.4 TREATMENT MONITORING
    • 9.4.1 LIQUID BIOPSY GAINING ATTENTION FOR REAL TIME TREATMENT MONITORING
    • TABLE 60 BREAST BIOPSY MARKET FOR TREATMENT MONITORING, BY REGION, 2018-2025 (USD MILLION)
  • 9.5 RECURRENCE MONITORING
    • 9.5.1 UNMET CLINICAL NEEDS CREATING OPPORTUNITIES FOR PLAYERS IN THE MARKET
    • TABLE 61 BREAST BIOPSY MARKET FOR RECURRENCE MONITORING, BY REGION, 2018-2025 (USD MILLION)

10 BREAST BIOPSY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 62 BREAST BIOPSY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 21 NORTH AMERICA: BREAST BIOPSY MARKET SNAPSHOT
    • TABLE 63 NORTH AMERICA: BREAST BIOPSY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 64 NORTH AMERICA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • TABLE 65 NORTH AMERICA: BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 66 NORTH AMERICA: NEEDLE BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 67 NORTH AMERICA: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 68 NORTH AMERICA: LIQUID BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 NORTH AMERICA: BREAST BIOPSY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 70 NORTH AMERICA: BREAST BIOPSY MARKET, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 71 NORTH AMERICA: IMAGE GUIDED BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 72 NORTH AMERICA: LIQUID BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Dominates the North American breast biopsy market
    • TABLE 73 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY PROCEDURES (2020)
    • TABLE 74 US: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Surge in breast cancer incidence and favorable government guidelines to support market growth
    • TABLE 75 CANADA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 76 EUROPE: BREAST BIOPSY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 77 EUROPE: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • TABLE 78 EUROPE: BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 79 EUROPE: NEEDLE BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 80 EUROPE: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 81 EUROPE: LIQUID BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 EUROPE: BREAST BIOPSY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 83 EUROPE: BREAST BIOPSY MARKET, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 84 EUROPE: IMAGE GUIDED BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 85 EUROPE: LIQUID BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Favorable reimbursement scenario to fuel adoption of biopsy tests
    • TABLE 86 GERMANY: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Public and private initiatives to increase awareness about breast cancer
    • TABLE 87 UK: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing geriatric population and rising awareness to support market growth
    • TABLE 88 FRANCE: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Evolving regulatory scenario for breast biopsy and rising incidence of cancer driving market
    • TABLE 89 ITALY: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growing geriatric population major reason for market growth
    • TABLE 90 SPAIN: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 91 ROE: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 22 ASIA PACIFIC: BREAST BIOPSY MARKET SNAPSHOT
    • TABLE 92 ASIA PACIFIC: BREAST BIOPSY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: NEEDLE BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: LIQUID BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 98 ASIA PACIFIC: BREAST BIOPSY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: BREAST BIOPSY MARKET, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: IMAGE GUIDED BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: LIQUID BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Increasing patient pool and government healthcare initiatives fueling market growth
    • TABLE 102 CHINA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Universal healthcare reimbursement scenario and rising breast cancer cases
    • TABLE 103 JAPAN: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Government initiatives to improve female health to drive market growth
    • TABLE 104 INDIA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Rising research investments and awareness campaigns supporting market growth
    • TABLE 105 AUSTRALIA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Rising R&D and promising clinical trials expected to positively impact market growth
    • TABLE 106 SOUTH KOREA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.4.6 REST OF APAC
    • TABLE 107 ROAPAC: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 108 LATIN AMERICA: BREAST BIOPSY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 109 LATIN AMERICA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • TABLE 110 LATIN AMERICA: BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 111 LATIN AMERICA: NEEDLE BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 112 LATIN AMERICA: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 113 LATIN AMERICA: LIQUID BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 114 LATIN AMERICA: BREAST BIOPSY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 115 LATIN AMERICA: BREAST BIOPSY MARKET, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 116 LATIN AMERICA: IMAGE GUIDED BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 117 LATIN AMERICA: LIQUID BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Key market due to increased screening programs
    • TABLE 118 BRAZIL: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Increasing awareness programs fueling market growth
    • TABLE 119 MEXICO: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.5.3 REST OF LA
    • TABLE 120 ROLA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • 10.5.4 MIDDLE EAST & AFRICA
      • 10.5.4.1 Improving healthcare infrastructure and increasing public-private investments to drive market growth
    • TABLE 121 MEA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018-2025 (USD MILLION)
    • TABLE 122 MEA: BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 123 MEA: NEEDLE BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 124 MEA: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 125 MEA: LIQUID BREAST BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 126 MEA: BREAST BIOPSY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 127 MEA: BREAST BIOPSY MARKET, BY GUIDANCE, 2018-2025 (USD MILLION)
    • TABLE 128 MEA: IMAGE GUIDED BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 129 MEA: LIQUID BIOPSY MARKET, BY TYPE, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
    • FIGURE 23 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO 2020
  • 11.2 MARKET SHARE ANALYSIS
    • FIGURE 24 GLOBAL NEEDLE BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2019
    • FIGURE 25 GLOBAL LIQUID BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2019
  • 11.3 KEY MARKET DEVELOPMENTS
    • 11.3.1 PRODUCT LAUNCHES AND APPROVALS
    • 11.3.2 ACQUISITIONS
    • 11.3.3 PARTNERSHIPS AND AGREEMENTS

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MNM view)**

  • 12.1 COMPANY EVALUATION MATRIX AND METHODOLOGY
    • 12.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019)
    • 12.1.2 VISIONARY LEADERS
    • 12.1.3 INNOVATORS
    • 12.1.4 DYNAMIC DIFFERENTIATORS
    • 12.1.5 EMERGING COMPANIES
  • 12.2 COMPANY EVALUATION MATRIX, 2019
    • FIGURE 26 BREAST BIOPSY MARKET (GLOBAL) COMEPITIVE LEADERSHIP MAPPING, 2019
  • 12.3 COMPANY PROFILES
    • 12.3.1 HOLOGIC, INC.
    • FIGURE 27 HOLOGIC, INC.: COMPANY SNAPSHOT
    • 12.3.2 DANAHER CORPORATION
    • FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT
    • 12.3.3 BECTON, DICKINSON AND COMPANY
    • FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
    • 12.3.4 ARGON MEDICAL
    • 12.3.5 IZI MEDICAL PRODUCTS
    • 12.3.6 MERIT MEDICAL SYSTEMS
    • FIGURE 30 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
    • 12.3.7 MENARINI SILICON BIOSYSTEMS SPA
    • 12.3.8 SCION MEDICAL TECHNOLOGIES, LLC
    • FIGURE 31 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
    • 12.3.9 MEDTRONIC
    • FIGURE 32 MEDTRONIC: COMPANY SNAPSHOT
    • 12.3.10 STERYLAB S.R.L.
    • 12.3.11 BIOCEPT, INC
    • FIGURE 33 BIOCEPT INC.: COMPANY SNAPSHOT
    • 12.3.12 BIO-RAD LABORATORIES, INC.
    • FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
    • 12.3.13 F. HOFFMANN-LA ROCHE LTD
    • FIGURE 35 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
    • 12.3.14 QIAGEN
    • FIGURE 36 QIAGEN: COMPANY SNAPSHOT
    • 12.3.15 EXACT SCIENCES CORPORATION
    • FIGURE 37 EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT
    • 12.3.16 OTHER COMPANIES
      • 12.3.16.1 Thermo Fisher Scientific
      • 12.3.16.2 Cardiff Oncology, Inc.
      • 12.3.16.3 Myriad Genetics, Inc.
      • 12.3.16.4 Illumina, INC
      • 12.3.16.5 Fluxion Biosciences, Inc.

*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Back to Top